In our study, we revealed the association between clinical parameters (age, NIHSS score, atrial fibrillation), as well as SNPs in the PTGS1, ADRA2A, TBXA2R and PEAR1 genes, and laboratory indicators of platelet activity in ischemic stroke patients taking aspirin for secondary stroke prevention. The gene discussed is ADRA2A; the disease is atrial fibrillation.